Clinical Trials
4 trialsNCT02394834 2026-04-13
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Takeda
Active not recruiting
NCT03043950 2024-04-24
VALIDATE
iOMEDICO AG
Completed
NCT01732783 2022-11-08
Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients
Amgen
Completed
NCT02089737 2017-04-06
Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)
Takeda
Completed